These final results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the thought of targeting ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-linked Issues. These effects suggest that conolidine https://josephu061ulc8.wikipowell.com/user